Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Covadonga Álvarez"'
Autor:
Zaid Dahma, Carlos Torrado-Salmerón, Covadonga Álvarez-Álvarez, Víctor Guarnizo-Herrero, Borja Martínez-Alonso, Guillermo Torrado, Santiago Torrado-Santiago, Paloma Marina de la Torre-Iglesias
Publikováno v:
Gels, Vol 10, Iss 3, p 207 (2024)
Meloxicam (MX) is a poorly water-soluble drug with severe gastrointestinal side effects. Topical hydrogel of hydroxypropyl guar (HPG) was formulated using a solid dispersion (SD) of MX with hydroxypropyl cellulose (LHPC) as an alternative to oral adm
Externí odkaz:
https://doaj.org/article/dfa8b2cdb3d74938847e77f04d9648cc
Autor:
Inmaculada Entrenas, Elena González‐Chamorro, Covadonga Álvarez‐Abad, Juan Muriel, Iván Menéndez‐Díaz, Teresa Cobo
Publikováno v:
Clinical and Experimental Dental Research, Vol 5, Iss 3, Pp 259-268 (2019)
Abstract The purpose of this prospective case control study is to describe in growing patients with mandibular hypoplasia, treatment outcomes following functional therapy in terms of volumetric changes in nasopharynx and oropharynx, that is, upper an
Externí odkaz:
https://doaj.org/article/af7cafcb4c9f4518ab17d67e36a16631
Autor:
Eva Navarro-Ruíz, Covadonga Álvarez-Álvarez, M Ángeles Peña, Carlos Torrado-Salmerón, Zaid Dahma, Paloma Marina de la Torre-Iglesias
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1504 (2022)
The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a higher pH than the re
Externí odkaz:
https://doaj.org/article/bbfb33b6ce1f43eab8c61549f0764acd
Autor:
Marta Amigo-Basilio, Covadonga Álvarez-González, Carlos Cobo-Vázquez, Isabel Leco-Berrocal, Luis Miguel Sáez-Alcaide, Cristina Méniz-García
Publikováno v:
Applied Sciences, Vol 11, Iss 11, p 4865 (2021)
Objective: The aim of this study is to know the biological therapy drugs that are related to adverse events, what dental treatments are associated with the appearance of these events, their severity, and how they are resolved. Study design: Analysis
Externí odkaz:
https://doaj.org/article/cad6586a268c4595a2e864c82c970958
Autor:
Mercedes Prieto-Escolar, Juan J. Torrado, Covadonga Álvarez, Alejandro Ruiz-Picazo, Marta Simón-Vázquez, Carlos Govantes, Jesús Frias, Alfredo García-Arieta, Isabel Gonzalez-Alvarez, Marival Bermejo
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 690 (2021)
Montelukast is a weak acid drug characterized by its low solubility in the range of pH 1.2 to 4.5, which may lead to dissolution-limited absorption. The aim of this paper is to develop an in vivo predictive dissolution method for montelukast and to c
Externí odkaz:
https://doaj.org/article/446e3baea8cc4e54a6b49eead7731b12
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John Gordon, Esperanza González-Rojano, Julio Marcotegui, Alfredo García-Arieta, Dolores Ochoa, Covadonga Álvarez, Francisco Abad-Santos, Manuel Román
Publikováno v:
Clinical Pharmacology & Therapeutics. 106:1099-1112
The US Food and Drug Administration recommends that if a drug product is intended for use in both sexes, similar proportions should be recruited for bioequivalence (BE) studies. In contrast, in Europe, subjects can belong to either sex. Literature su
Autor:
Juan J. Torrado, Marival Bermejo, Jesús Frías, Carlos Govantes, Covadonga Álvarez, Isabel González-Álvarez, Mercedes Prieto-Escolar, Alfredo García-Arieta, Marta Simón-Vázquez, Alejandro Ruiz-Picazo
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 690, p 690 (2021)
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Volume 13
Issue 5
E-Prints Complutense. Archivo Institucional de la UCM
Pharmaceutics, Vol 13, Iss 690, p 690 (2021)
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Volume 13
Issue 5
E-Prints Complutense. Archivo Institucional de la UCM
Montelukast is a weak acid drug characterized by its low solubility in the range of pH 1.2 to 4.5, which may lead to dissolution-limited absorption. The aim of this paper is to develop an in vivo predictive dissolution method for montelukast and to c
Autor:
Quintana, Covadonga Álvarez
Publikováno v:
Ábaco, 1996 Jan 01(8), 47-56.
Externí odkaz:
https://www.jstor.org/stable/20795769
Autor:
Manuel Román, Francisco Abad-Santos, Dolores Ochoa, John Gordon, Esperanza González-Rojano, Covadonga Álvarez, Alfredo García-Arieta, Julio Marcotegui
Publikováno v:
British Journal of Clinical Pharmacology. 84:1729-1737
Aims The existence of a sex-by-formulation interaction in bioequivalence studies implies that the bioequivalence results (i.e., the test/reference ratio of the pharmacokinetic parameters) obtained in one sex are not similar to those obtained in the o